Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Consolidated Net Income: 2016-2025

Historic Consolidated Net Income for Assembly Biosciences (ASMB) over the last 9 years, with Sep 2025 value amounting to -$9.2 million.

  • Assembly Biosciences' Consolidated Net Income rose 4.34% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.2 million, marking a year-over-year increase of 4.03%. This contributed to the annual value of -$40.2 million for FY2024, which is 34.38% up from last year.
  • Per Assembly Biosciences' latest filing, its Consolidated Net Income stood at -$9.2 million for Q3 2025, which was down 4.29% from -$8.8 million recorded in Q2 2025.
  • Assembly Biosciences' 5-year Consolidated Net Income high stood at -$8.8 million for Q1 2025, and its period low was -$62.8 million during Q4 2021.
  • Its 3-year average for Consolidated Net Income is -$11.7 million, with a median of -$9.6 million in 2024.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first slumped by 461.45% in 2021, then skyrocketed by 52.10% in 2024.
  • Quarterly analysis of 4 years shows Assembly Biosciences' Consolidated Net Income stood at -$62.8 million in 2021, then reached -$11.0 million in 2023, then grew by 5.72% to -$10.3 million in 2024, then increased by 4.34% to -$9.2 million in 2025.
  • Its last three reported values are -$9.2 million in Q3 2025, -$8.8 million for Q2 2025, and -$8.8 million during Q1 2025.